VASOACTIVE PEPTIDES IN EXPERIMENTAL RENAL-HYPERTENSION

被引：9

作者：

JOHNSTON, CI

PULLAN, PT

WALTER, NMA

机构：

来源：

KLINISCHE WOCHENSCHRIFT | 1978年 / 56卷

关键词：

D O I：

10.1007/BF01477457

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：81 / 85

页数：5

共 25 条

[11]

JOHNSTON CI, 1969, P AUST SOC MED RES, V2, P271

[12]

JOHNSTON CI, 1976, SYSTEMIC EFFECTS ANT, P323

[13]

KHOKHAR AM, 1976, CLIN SCI MOL MED, V51, pS691, DOI 10.1042/cs051691s

[14]

KOLETSKY S, 1966, P SOC EXP BIOL MED, V122, P941

[15]

LOUIS WJ, 1974, CIRC RES, V34, pI57

[16] EFFECTS OF ALDOSTERONE AND SPIRONOLACTONE ON RENAL KALLIKREIN IN RAT [J].

MARGOLIUS, HS ;

CHAO, J ;

KAIZU, T .

CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1976, 51 :S279-S282

[17] URINARY KALLIKREIN EXCRETION IN NORMAL MAN - RELATIONSHIPS TO SODIUM INTAKE AND SODIUM-RETAINING STEROIDS [J].

MARGOLIUS, HS ;

HORWITZ, D ;

GELLER, RG ;

ALEXANDER, RW ;

GILL, JR ;

PISANO, JJ ;

KEISER, HR .

CIRCULATION RESEARCH, 1974, 35 (06) :812-819

[18] VASOPRESSOR ROLE OF ADH IN PATHOGENESIS OF MALIGNANT DOC HYPERTENSION [J].

MOHRING, J ;

MOHRING, B ;

PETRI, M ;

HAACK, D .

AMERICAN JOURNAL OF PHYSIOLOGY, 1977, 232 (03) :F260-F269

[19]

PADFIELD PL, 1976, LANCET, V1, P1255

[20] ROLE OF PRESSOR ACTION OF ANGIOTENSIN-II EXPERIMENTAL HYPERTENSION [J].

PALS, DT ;

MASUCCI, FD ;

DENNING, GS ;

SIPOS, F ;

FESSLER, DC .

CIRCULATION RESEARCH, 1971, 29 (06) :673-&

← 1 2 3 →